EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma

Xiaofei Hao, Huan Du, Binwei Lin, Mingming Tang, Huayan Zhang, Decai Wang, Yihan Zhu, Hu Long, Hanjie Liu, Xiaobo Du

European Journal of Pharmaceutics and Biopharmaceutics · 2026-08 · 225 · 115123

DOI: 10.1016/j.ejpb.2026.115123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-08. Verfasst von Xiaofei Hao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang 621000, PR China; NHC Key Laborator…. Hauptthemen laut MEDLINE: Skin Neoplasms, Radioisotopes, Melanoma, Zirconium. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsRadioisotopesMelanomaZirconiumAntibodies, MonoclonalLutetiumAnimalsHumansMiceCell Line, TumorTissue DistributionXenograft Model Antitumor AssaysFemaleRadioimmunotherapyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsCutaneous Malignant MelanomaTheranostic NanomedicineMice, Nude

Stichwörter der Autor:innen

CD228Lutetium-177Radioimmuno therapySkin cutaneous melanomaTerbium-161

Substanzen

RadioisotopesZirconiumAntibodies, MonoclonalLutetiumZirconium-89Lutetium-177Radiopharmaceuticals

Autor:innen und Institutionen

  • Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang 621000, PR China; NHC Key Laboratory of Nuclear Technology Medical Transformation (MIANYANG CENTRAL HOSPI…
  • Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang 621000, PR China.
  • North Sichuan Medical College, Nanchong 637000, PR China.
  • Southwest University of Science and Technology, Mianyang 621010, PR China.
  • Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Chengdu 611130, PR China.

Zitieren

APA

Hao, X., Du, H., Lin, B., Tang, M., Zhang, H., Wang, D., Zhu, Y., Long, H., Liu, H., & Du, X. (2026). Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma. European Journal of Pharmaceutics and Biopharmaceutics, 225, 115123. https://doi.org/10.1016/j.ejpb.2026.115123

Vancouver

Hao X, Du H, Lin B, Tang M, Zhang H, Wang D, et al. Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma. European Journal of Pharmaceutics and Biopharmaceutics. 2026;225:115123. doi:10.1016/j.ejpb.2026.115123

BibTeX
@article{Hao2026,
  author = {Hao, Xiaofei and Du, Huan and Lin, Binwei and Tang, Mingming and Zhang, Huayan and Wang, Decai and Zhu, Yihan and Long, Hu and Liu, Hanjie and Du, Xiaobo},
  title = {Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  volume = {225},
  pages = {115123},
  doi = {10.1016/j.ejpb.2026.115123}
}
Kostenlos starten →